USD10
AVBP acciones
Acerca de ArriVent BioPharmaArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
USD10
AVBP acciones
Acerca de ArriVent BioPharmaArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
25 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
906,13 M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
15,47 US$
ALTO (1Y)
28,12 US$
BAJO (24H)
21,09 US$
Alza (24H)
22,21 US$
Volumen (24 h)
227,87 mil US$
17,97 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | No hay suficientes datos | No hay suficientes datos |
1 día | 21,91 US$ | |
1 semana | 24,10 US$ | |
1 mes | 23,47 US$ | |
1 año | 18,28 US$ |